Research graph
References from Toripalimab consolidation after chemoradiotherapy in limited-stage small cell lung cancer: a phase II, randomized controlled study (GASTO-1052A). Local targets link to admitted publications; unresolved targets remain external evidence.
10.1200/jco.2005.04.4859
10.1200/jco.2005.04.4859 · External reference
10.1002/cncr.29098
10.1002/cncr.29098 · External reference
10.1016/j.annonc.2021.03.207
10.1016/j.annonc.2021.03.207 · External reference
10.6004/jnccn.2021.0058
10.6004/jnccn.2021.0058 · External reference
High-Dose Once-Daily Thoracic Radiotherapy in Limited-Stage Small-Cell Lung Cancer: CALGB 30610 (Alliance)/RTOG 0538
10.1200/jco.22.01359 · 2023 · External reference
10.1016/s1470-2045(17)30318-2
10.1016/s1470-2045(17)30318-2 · External reference
10.1056/nejmoa1809064
10.1056/nejmoa1809064 · External reference
Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial
10.1016/s0140-6736(19)32222-6 · 2019 · External reference
Toripalimab Plus Chemotherapy as a First-Line Therapy for Extensive-Stage Small Cell Lung Cancer: The Phase 3 EXTENTORCH Randomized Clinical Trial
10.1001/jamaoncol.2024.5019 · 2025 · External reference
10.1056/nejmoa2404873
10.1056/nejmoa2404873 · External reference
Chemoradiation ± Atezolizumab in Limited-Stage Small Cell Lung Cancer: Results of NRG Oncology/Alliance LU005
10.1200/jco-25-01569 · 2026 · External reference
10.3322/caac.21388
10.3322/caac.21388 · External reference
10.1016/j.ijrobp.2021.05.003
10.1016/j.ijrobp.2021.05.003 · External reference
10.1201/9780367805326
10.1201/9780367805326 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
Timing Is of the Essence: Sequencing Immune Checkpoint Blockade and Radiotherapy for Success in Lung Cancer
10.1200/jco-25-02726 · 2026 · External reference
LBA81 Durvalumab (D) as consolidation therapy in limited-stage SCLC (LS-SCLC): Outcomes by prior concurrent chemoradiotherapy (cCRT) regimen and prophylactic cranial irradiation (PCI) use in the Adriatic trial
10.1016/j.annonc.2024.08.2324 · 2024 · External reference
Skull bones harbour immune cells that are poised to target brain tumours
10.1038/d41586-024-02789-5 · 2024 · External reference
Redefining CNS immune privilege
10.1038/s41577-025-01175-0 · 2025 · External reference
10.1016/s1470-2045(16)30065-1
10.1016/s1470-2045(16)30065-1 · External reference
Ionizing Radiation-Induced Immune and Inflammatory Reactions in the Brain
10.3389/fimmu.2017.00517 · 2017 · External reference
10.1016/j.smim.2020.101435
10.1016/j.smim.2020.101435 · External reference
Resident and circulating memory T cells persist for years in melanoma patients with durable responses to immunotherapy
10.1038/s43018-021-00180-1 · 2021 · External reference
10.1158/0008-5472.can-14-1258
10.1158/0008-5472.can-14-1258 · External reference
10.1158/0008-5472.can-12-1187
10.1158/0008-5472.can-12-1187 · External reference
